Global Tumor Ablation Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2015 to 2025

  • ID: 4313237
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Angiodynamics, Inc.
  • BVM Medical Limited
  • Galil Medical, Inc.
  • INTIO Inc.
  • Mermaid Medical, Inc.
  • Neuwave Medical, Inc.
  • MORE
Tumor Ablation Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025 the global tumor ablation market was valued at US$ 396.89 Mn in 2016, and is expected to reach US$ 1,208.93 Mn by 2025, expanding at a CAGR of 13.2% from 2017 to 2025.

Market Insights
Tumor ablation is a minimally invasive procedure that is commonly used in the treatment of tumors of liver, kidney, bone, and lung; special probes are used to burn or freeze tumor without the surgery. Factors such as growing prevalence of different forms of cancer and growing awareness regarding the benefits offered by ablation procedures over conventional surgical procedures are fueling the growth of tumor ablation market globally. For the purpose of study, global tumor ablation market is segmented on the basis of technology such as radiofrequency ablation, microwave ablation, cryoablation and other technologies. Currently, radiofrequency ablation held largest market share because it is a commonly used method to treat cancer in bone, kidney, liver, lung and prostate. Faster recovery by radiofrequency ablation would influence the growth of radiofrequency ablation market globally. On the basis of treatment, this market is categorized as surgical ablation, laparoscopic ablation and percutaneous ablation. In the base year 2016, surgical ablation is major revenue generating segment due its wide range of applicability in removing solid tumors.

On the basis of application, the global tumor ablation market is categorized as liver cancer, lung cancer, kidney cancer, bone metastasis and other applications; liver cancer held largest market share as tumor ablation is widely used in treatment of solid tumors in liver. Tumor ablation market is currently dominated by North America due to factors such as technological advances, advanced healthcare infrastructure and high prevalence of cancer are influencing market growth in North America.

Market Competition Assessment:
The tumor ablation market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Angiodynamics, Inc., Boston Scientific Corp., BVM Medical Limited, EDAP TMS S.A., Galil Medical, Inc., Healthtronics, Inc., INTIO Inc., Medtronic, Plc., Mermaid Medical, Inc., Mesonix, Inc., Neuwave Medical, Inc., Sonacare Medical, LLC and other.

Key Market Movements:
  • Factors such as rising prevalence of different forms of cancer, technological advancements in the field of ablation, rising awareness regarding the benefits offered by ablation procedures over the conventional surgical procedures and rising number of hospitals, surgical, and ablation centers are driving the growth of tumor ablation market globally.
  • However, stringent regulatory guidelines leading to increase in period of product launches and therapeutic challenges related to ablation procedures are negatively impacting the growth of tumor ablation market worldwide.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Angiodynamics, Inc.
  • BVM Medical Limited
  • Galil Medical, Inc.
  • INTIO Inc.
  • Mermaid Medical, Inc.
  • Neuwave Medical, Inc.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 Usp and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Tumor Ablation Market Snapshot
2.2 Global Tumor Ablation Market, by Technology, 2016 (US$ Bn)
2.3 Global Tumor Ablation Market, by Treatment, 2016 (US$ Bn)
2.4 Global Tumor Ablation Market, by Application, 2016 (US$ Bn)
2.5 Global Tumor Ablation Market Share, by Geography, 2016 (Value %)

Chapter 3 Tumor Ablation Market Analysis
3.1 Global Tumor Ablation Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Increase in Demand for Minimally Invasive Cancer Procedures
3.2.1.2 Rising Prevalence of Cancer
3.2.2 Challenges
3.2.2.1 Stringent Regulatory Guidelines
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Tumor Ablation Market

Chapter 4 Global Tumor Ablation Market, by Technology
4.1 Overview
4.2 Radiofrequency Ablation
4.3 Microwave Ablation
4.4 Cryoablation
4.5 Other Technologies

Chapter 5 Global Tumor Ablation Market, by Treatment
5.1 Overview
5.2 Surgical Ablation
5.3 Laparoscopic Ablation
5.4 Percutaneous Ablation

Chapter 6 Global Tumor Ablation Market, by Application
6.1 Overview
6.2 Liver Cancer
6.3 Lung Cancer
6.4 Kidney Cancer
6.5 Bone Metastasis
6.6 Other Application

Chapter 7 Global Tumor Ablation Market, by Geography
7.1 Preface
7.2 North America (U.S. & Canada)
7.3 Europe (U.K., Germany & Rest of Europe)
7.4 Asia Pacific (China, Japan and Rest of Apac)
7.5 Latin America
7.6 Middle East and Africa

Chapter 8 Company Profiles
8.1 Angiodynamics, Inc
8.2 Boston Scientific Corp
8.3 Bvm Medical Limited
8.4 Edap Tms S.A
8.5 Galil Medical, Inc
8.6 Healthtronics, Inc
8.7 Intio Inc
8.8 Medtronic, Plc
8.9 Mermaid Medical, Inc
8.10 Mesonix, Inc
8.11 Neuwave Medical, Inc
8.12 Sonacare Medical, Llc

List of Figures
Figure 1 Tumor Ablation Market: Research Methodology
Figure 2 Global Tumor Ablation Market, by Technology, 2016 (US$ Bn)
Figure 3 Global Tumor Ablation Market, by Treatment, 2016 (US$ Bn)
Figure 4 Global Tumor Ablation Market, by Application, 2016 (US$ Bn)
Figure 5 Global Tumor Ablation Market Share, by Geography, 2016 (Value %)
Figure 6 Attractive Investment Proposition: Global Tumor Ablation Market, by Geography, 2016
Figure 7 Global Radiofrequency Ablation Market for Tumor Ablation, 2015 - 2025 (US$ Bn)
Figure 8 Global Microwave Ablation Market for Tumor Ablation, 2015 - 2025 (US$ Bn)
Figure 9 Global Cryoablation Market for Tumor Ablation, 2015 - 2025 (US$ Bn)
Figure 10 Global Other Technologies Market for Tumor Ablation, 2015 - 2025 (US$ Bn)
Figure 11 Global Tumor Ablation Market for Surgical Ablation, 2015 - 2025 (US$ Bn)
Figure 12 Global Tumor Ablation Market for Laparoscopic Ablation, 2015 - 2025 (US$ Bn)
Figure 13 Global Tumor Ablation Market for Percutaneous Ablation, 2015 - 2025 (US$ Bn)
Figure 14 Global Tumor Ablation Market for Liver Cancer, 2015 - 2025 (US$ Bn)
Figure 15 Global Tumor Ablation Market for Lung Cancer, 2015 - 2025 (US$ Bn)
Figure 16 Global Tumor Ablation Market for Kidney Cancer, 2015 - 2025 (US$ Bn)
Figure 17 Global Tumor Ablation Market for Bone Metastasis, 2015 - 2025 (US$ Bn)
Figure 18 Global Tumor Ablation Market for Other Application, 2015 - 2025 (US$ Bn)
Figure 19 Latin America Tumor Ablation Market, 2015 - 2025 (US$ Bn)
Figure 20 Middle East and Africa Tumor Ablation Market, 2015 - 2025 (US$ Bn)

List of Tables
Table 1 Market Positioning of Key Players in Global Tumor Ablation Market
Table 2 Global Tumor Ablation Market, by Technology, 2015 - 2025 (US$ Bn)
Table 3 Global Tumor Ablation Market, by Treatment, 2015 - 2025 (US$ Bn)
Table 4 Global Tumor Ablation Market, by Application, 2015 - 2025 (US$ Bn)
Table 5 Global Tumor Ablation Market, by Geography, 2015 - 2025 (US$ Bn)
Table 6 North America Tumor Ablation Market, by Country, 2015 - 2025 (US$ Bn)
Table 7 Europe Tumor Ablation Market, by Country, 2015 - 2025 (US$ Bn)
Table 8 Asia Pacific Tumor Ablation Market, by Country, 2015 - 2025 (US$ Bn)
Table 9 Angiodynamics, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 10 Boston Scientific Corp.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 11 Bvm Medical Limited: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 12 Edap Tms S.A.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 13 Galil Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 14 Healthtronics, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 15 Intio Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 16 Medtronic, Plc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 17 Mermaid Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 18 Mesonix, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 19 Neuwave Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 20 Sonacare Medical, Llc: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Angiodynamics, Inc.
  • Boston Scientific Corp.
  • BVM Medical Limited
  • EDAP TMS S.A.
  • Galil Medical, Inc.
  • Healthtronics, Inc.
  • INTIO Inc.
  • Medtronic, Plc.
  • Mermaid Medical, Inc.
  • Mesonix, Inc.
  • Neuwave Medical, Inc.
  • Sonacare Medical, LLC
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll